HEAD OF PROGRAM

ACADEMIC STAFF

• Ilja Arts
  
• Jan-Willem Cohen Tervaert
  
• Pieter Dagnelie
  
• Adriaan Duijvestijn
  
• Isabel Ferreira
  
• Marleen van Greevenbroek
  
• Boy Houben
  
• Carla van der Kallen
  
• Casper Schalkwijk
  

POST-DOC

• Olaf Brouwers
  
• Marcelle van Eupen
  
• Katrien Gaens
  
• Ronald Henry
  
• Miranda Schram
  
• Simone Sep
  

PhD STUDENTS

• Bart Eskens
  
• Nordin Hanssen
  
• Elisabeth Hertle
  
• Yvo Kusters
  
• Roel van de Laar
  
• Dennis Muris
  
• Thomas van Sloten
  

TECHNICAL STAFF

• Joyce Akse
  
• Marie-Jose van de Gaar
  
• Josephine van Lin
  
• Bernarda Meessen
  
• Petra Niessen
  
• Margee Robertus
  
• Vicky Vermeulen
  
• Maria Vroomen
  
• Marjo van de Waarenburg
  

Related publications

• published on 14-09-2010
  Arterial calcifications
• published on 23-07-2010
  Inhibition of thrombin formation by active site mutated (S360A) activated protein C
• published on 01-09-2010
  Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability as determined by thrombin generation in plasma: the role of central obesity and low-grade inflammation. The Hoorn Study
• published on 01-12-2010
  Body composition as determinant of thrombin generation in plasma: the Hoorn study
• published on 01-12-2010
  Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus
• published on 01-08-2010
  Angiotensin II enhances insulin-stimulated whole-body glucose disposal but impairs insulin-induced capillary recruitment in healthy volunteers
• published on 01-10-2010
  Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity-but not a PCOS-associated phenomenon
• published on 01-04-2010
  Distinct ethnic differences in lipid profiles across glucose categories
• published on 01-05-2010
  Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress
• published on 01-05-2010
  Irbesartan treatment does not influence plasma levels of the advanced glycation end products CML and CEL in patients with type 2 diabetes and microalbuminuria. An IRMA2 substudy
• published on 01-09-2010
  Urinary D-lactate levels are increased in type 2 diabetic patients and are inversely associated with ankle arm index: The CODAM study
• published on 01-08-2010
  Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial
• published on 01-09-2010
  The inverse association between alcohol intake and complement C3 can be attributed to wine consumption and is explained by inflammation, HDL and insulin resistance, the CODAM study
• published on 01-09-2010
  Diabetes, prediabetes and cancer mortality
• published on 01-01-2010
  Lifetime vigorous but not light-to-moderate habitual physical activity impacts favorably on carotid stiffness in young adults: the amsterdam growth and health longitudinal study
• published on 01-06-2010
  Hyperglycemia and oxidative stress strengthen the association between myeloperoxidase and blood pressure
• published on 01-06-2010
  Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion
• published on 01-08-2010
  Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study
• published on 01-10-2010
  Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'
• published on 20-05-2010
  Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial
• published on 09-01-2010
  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Emerging Risk Factors Collaboration.
• published on 26-06-2010
  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
• published on 01-03-2011
  Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes
• published on 05-08-2011
  Abdominal Fat Mass Is Associated With Adaptive Immune Activation: The CODAM Study
• published on 05-09-2011
  Irbesartan treatment does not influence plasma levels of the advanced glycation end products N{varepsilon}(1-carboxymethyl)lysine and N{varepsilon}(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial
• published on 05-09-2011
  Immune complexes in acute adult-onset Henoch-Schonlein nephritis
• published on 05-09-2011
  The association between the metabolic syndrome and peripheral, but not coronary, artery disease is partly mediated by endothelial dysfunction: the CODAM study
• published on 05-09-2011
  The cross-sectional association between insulin resistance and circulating complement C3 is partly explained by plasma alanine aminotransferase, independent of central obesity and general inflammation (the CODAM study)
• published on 05-09-2011
  Neutrophils and T cells: Bidirectional effects and functional interferences